105 related articles for article (PubMed ID: 38484745)
1. The future of onchocerciasis control in Africa.
Hodgkin C; Molyneux DH; Abiose A; Philippon B; Reich MR; Remme JH; Thylefors B; Traore M; Grepin K
PLoS Negl Trop Dis; 2007 Oct; 1(1):e74. PubMed ID: 17989787
[No Abstract] [Full Text] [Related]
2. The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa.
Makepeace BL; Babayan SA; Lustigman S; Taylor DW
Expert Rev Vaccines; 2015; 14(9):1163-5. PubMed ID: 26091691
[TBL] [Abstract][Full Text] [Related]
3. Review of Ethiopian Onchocerciasis Elimination Programme.
Meribo K; Kebede B; Feleke SM; Mengistu B; Mulugeta A; Sileshi M; Samuel A; Deribe K; Tadesse Z
Ethiop Med J; 2017; 55(Suppl 1):55-63. PubMed ID: 28878430
[TBL] [Abstract][Full Text] [Related]
4. Optimized strategy for real-time qPCR detection of Onchocerca volvulus DNA in pooled Simulium sp. blackfly vectors.
Doherty M; Grant JR; Pilotte N; Bennuru S; Fischer K; Fischer PU; Lustigman S; Nutman TB; Pfarr K; Hoerauf A; Unnasch TR; Hassan HK; Wanji S; Lammie PJ; Ottesen E; Mackenzie C; Williams SA
PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011815. PubMed ID: 38096317
[TBL] [Abstract][Full Text] [Related]
5. River blindness: a success story under threat?
Basáñez MG; Pion SD; Churcher TS; Breitling LP; Little MP; Boussinesq M
PLoS Med; 2006 Sep; 3(9):e371. PubMed ID: 17002504
[TBL] [Abstract][Full Text] [Related]
6. Time series analysis of onchocerciasis data from Mexico: a trend towards elimination.
Lara-Ramírez EE; Rodríguez-Pérez MA; Pérez-Rodríguez MA; Adeleke MA; Orozco-Algarra ME; Arrendondo-Jiménez JI; Guo X
PLoS Negl Trop Dis; 2013; 7(2):e2033. PubMed ID: 23459370
[TBL] [Abstract][Full Text] [Related]
7. Effects of paediatric schistosomiasis control programmes in sub-Saharan Africa: A systematic review.
Vere M; Ten Ham-Baloyi W; Melariri PE
PLoS One; 2024; 19(5):e0301464. PubMed ID: 38696510
[TBL] [Abstract][Full Text] [Related]
8. Field sensitivity and specificity of the SD BIOLINE onchocerciasis IgG4 Rapid Diagnostic Test in children <10 years old from endemic areas in Burkina Faso.
Nikièma AS; Koala L; Unnasch TR; Diendéré J; Compaoré J; Ouédraogo MW; Kafando CM; Bakajika D; Bougouma C; Faye B; Traoré S; Dabiré RK
Parasite Epidemiol Control; 2024 May; 25():e00352. PubMed ID: 38708128
[TBL] [Abstract][Full Text] [Related]
9. Pediatric brain tumors in sub-Saharan Africa: a systematic review and meta-analysis.
Nyalundja AD; Kanmounye US; Karekezi C; Laeke T; Thango N; Balogun JA
J Neurosurg Pediatr; 2024 Jun; 33(6):524-535. PubMed ID: 38489811
[TBL] [Abstract][Full Text] [Related]
10. Incidence and predictors of postoperative complications in Sub-Saharan Africa: a systematic review and meta-analysis.
Yadeta DA; Manyazewal T; Demessie DB; Kleive D
Front Health Serv; 2024; 4():1353788. PubMed ID: 38784705
[TBL] [Abstract][Full Text] [Related]
11. Lingering challenges in malaria elimination efforts in sub-Saharan Africa: Insights and potential solutions.
Lawal L; Buhari AO; Jaji TA; Alatare AS; Adeyemo AO; Olumoh AO; Yusuff YA; Osborn G; Mogaji AB; Adoto BH; Ibrahim NG; Saliu WO; Abdul-Rahman T
Health Sci Rep; 2024 Jun; 7(6):e2122. PubMed ID: 38831778
[TBL] [Abstract][Full Text] [Related]
12. Scorecard Approach to Eliminate Onchocerciasis in Venezuela.
Camacho O; Botto C; Ríos D; Barrios B; Ceballos S; Noya-Alarcón O; Fernández M; Tovar Y; Villamizar NJ; Rakers L; Richards F; Grillet ME
Am J Trop Med Hyg; 2024 Jun; ():. PubMed ID: 38861970
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and diagnosis of gout in sub-saharan Africa: a scoping review.
Ismael AT; Fulgence K; Tchenadoyo BYL; Nadège YW; Stéphanie Joelle ZW; Aboubakar O; Enselme ZY; Awa T; Marcellin B; Dieu-Donné O
BMC Rheumatol; 2024 May; 8(1):21. PubMed ID: 38783360
[TBL] [Abstract][Full Text] [Related]
14. Measuring and modelling the effects of systematic non-adherence to mass drug administration.
Dyson L; Stolk WA; Farrell SH; Hollingsworth TD
Epidemics; 2017 Mar; 18():56-66. PubMed ID: 28279457
[TBL] [Abstract][Full Text] [Related]
15. Modelling techniques in cholera epidemiology: A systematic and critical review.
Anteneh LM; Lokonon BE; Kakaï RG
Math Biosci; 2024 May; 373():109210. PubMed ID: 38777029
[TBL] [Abstract][Full Text] [Related]
16. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
19. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
